Abbott Laboratories

NYSE: ABT
$117.37
+$1.47 (+1.3%)
Closing Price on November 18, 2024

ABT Articles

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed...
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are...
Stocks opened down this morning following the earnings report Apple Inc. (NASDAQ: AAPL) after markets closed yesterday. Moody’s downgrade of Spain’s sovereign debt also weighed on the opening....
Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public.  So what about when a company decides to unlock shareholder value by breaking itself...
MSNBC: US housing starts jumped in September http://on.msnbc.com/pxVyNE NYT: Olympus Backtracks on Payments http://nyti.ms/pAPNmD CNNMoney: Apple 2.0: Apple’s big miss: The analysts weigh in...
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession....
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston...
Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend and improve quality of life, a great many others may not be...
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition.  While this is a challenge...
Google (NASDAQ: GOOG) was sued by PayPal and Ebay (NASDAQ: EBAY) over the use of trade secrets in its new e-commerce payment system. (Reuters) A power shortage in China may cause the government to...
It is almost every day that we take a look at the market capitalization rates of some of America’s largest public companies in our own Real-Time 500 reading.  The recession killed many stocks and...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday morning. Abbott Laboratories (NYSE: ABT) Maintained Hold but cut estimates at...
Brent crude rose $6 to $113 on worries about Middle East contagion. (Reuters) GM (NYSE: GM) is likely to post its first annual profit since 2004. (Reuters) An effort by shareholders to get Apple...